Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
ROSEN, A TOP RANKED FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESO (11/20/2020)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Operational and Financial Results for the Period Ended September 30, 2020 (11/19/2020)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Mesoblast Corporate Update and Financial Results Webcast (11/19/2020)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action - MESO (11/19/2020)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-L (11/19/2020)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Novartis (NVS) Partners With Mesoblast for ARDS Cell Therapy (11/20/2020)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Mesoblast Limited Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm (11/18/2020)
view